Cyclacel Sales General And Administrative To Revenue from 2010 to 2024
| CYCCP Preferred Stock | USD 5.80 0.04 0.69% |
Check Cyclacel Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cyclacel Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cyclacel financial statements analysis is a perfect complement when working with Cyclacel Pharmaceuticals Valuation or Volatility modules.
Cyclacel |
About Cyclacel Pharmaceuticals Financial Statements
Cyclacel Pharmaceuticals shareholders use historical fundamental indicators, such as Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Although Cyclacel Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Cyclacel Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cyclacel Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Pair Trading with Cyclacel Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyclacel Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Cyclacel Preferred Stock
| 0.66 | VAXX | Vaxxinity | PairCorr |
| 0.65 | EVLO | Evelo Biosciences | PairCorr |
| 0.56 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.53 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.51 | FRTX | Fresh Tracks Therapeutics | PairCorr |
The ability to find closely correlated positions to Cyclacel Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyclacel Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyclacel Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyclacel Pharmaceuticals to buy it.
The correlation of Cyclacel Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyclacel Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyclacel Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyclacel Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.